The 10th anniversary this week of the day Congress signed the President’s Emergency Plan For AIDS Relief into law has prompted celebration, reflection, caution, and a look at the road travelled, in What We’re Reading . . . Ten Years of Saving Millions of Lives: “Landmark scientific advances, coupled with lessons learned from a decade […]
HIV
The goals of controlling HIV sound like a straight forward series of three consecutive steps, one following another, when discussed in global and domestic epidemic-ending plans. […]
Tuberculosis
The announcement Wednesday of U.S. Food and Drug Administration approval of pretomanid, a new tuberculosis drug that has been part of a ground-breaking treatment regimen against […]
Research & Development
A randomized, multi-country clinical trial testing a regimen for treating drug-resistant tuberculosis in less than a year against the up to two-year regimen recommended by the […]
Policy
The following is a guest post by Jacqueline Hellen and Lisa Parker of MEASURE Evaluation While programs in low- and middle-income countries seek to support children […]